TABLE II. Number and proportion of children according to the outcome after yellow fever vaccination and the type of vaccine.

	Vaccine		p
	17D-213/77 n/N (%)	17DD n/N (%)
Seropositive individuals (≥ 2.80 mIU/mL) (full cohort)	803/981 (81.9)	820/985 (83.2)	0.184
Seroconversion among seronegative individuals before vaccinationa	725/855 (84.8)	715/852 (85.8)	0.597
Ratio of post-vaccination/ pre-vaccination titresb ≥ 4	761/981 (77.6)	806/985 (81.8)	0.131

a: excludes pre-vaccination antibody titres ≥ 2.70 mIU/mL and missing data; b: includes all with results of serologic testing.